flurazepam has been researched along with glutamic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shibata, S; Tominaga, K; Ueki, S; Watanabe, S | 1 |
| Vellucci, SV; Webster, RA | 1 |
| Avoli, M; Brancati, A; Frank, C; Tancredi, V; White, P | 1 |
| Starr, MS | 1 |
| Cherubini, E; Conti, F; Fattorini, G; Safiulina, VF | 1 |
| Greenfield, LJ; Shen, G; Song, J; Tietz, EI | 1 |
| Lebida, K; Mozrzymas, JW; Wójtowicz, T | 1 |
| Shen, G; Tietz, EI; Van Sickle, BJ | 1 |
8 other study(ies) available for flurazepam and glutamic acid
| Article | Year |
|---|---|
Effects of inhibitory and excitatory drugs on the metabolic rhythm of the hamster suprachiasmatic nucleus in vitro.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Circadian Rhythm; Cricetinae; Deoxyglucose; Dose-Response Relationship, Drug; Flurazepam; Glutamates; Glutamic Acid; Male; Mesocricetus; Muscimol; Neurons; Pentobarbital; Potassium Chloride; Suprachiasmatic Nucleus; Tetrodotoxin | 1992 |
GABA and benzodiazepine-induced modification of [14C]L-glutamic acid release from rat spinal cord slices.
Topics: Aminooxyacetic Acid; Animals; Bicuculline; Drug Interactions; Flurazepam; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; In Vitro Techniques; Male; Potassium; Rats; Spinal Cord | 1985 |
Interactions between amino acid neurotransmitters and flurazepam in the neocortex of unanesthetized rats.
Topics: Amino Acids; Animals; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Interactions; Flurazepam; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glycine; Neurotransmitter Agents; Rats; Rats, Inbred Strains | 1983 |
Specificity of GABA as a stimulator of dopamine release in rat substantia nigra.
Topics: Amino Acids; Animals; Dopamine; Flurazepam; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; In Vitro Techniques; Male; Picrotoxin; Potassium; Rats; Rats, Inbred Strains; Sodium; Structure-Activity Relationship; Substantia Nigra | 1980 |
GABAergic signaling at mossy fiber synapses in neonatal rat hippocampus.
Topics: Action Potentials; Aminobutyrates; Animals; Animals, Newborn; Bicuculline; Cation Transport Proteins; Dentate Gyrus; Electric Stimulation; Excitatory Amino Acid Agonists; Flurazepam; GABA Uptake Inhibitors; gamma-Aminobutyric Acid; Glutamic Acid; Interneurons; Mossy Fibers, Hippocampal; Nipecotic Acids; Oximes; Patch-Clamp Techniques; Phosphinic Acids; Picrotoxin; Propanolamines; Pyramidal Cells; Quinoxalines; Rats; Rats, Wistar; Reaction Time; Receptors, AMPA; Receptors, GABA-A; Synaptic Transmission; Vesicular Glutamate Transport Protein 1 | 2006 |
Benzodiazepine withdrawal-induced glutamatergic plasticity involves up-regulation of GluR1-containing alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in Hippocampal CA1 neurons.
Topics: Adaptor Proteins, Signal Transducing; Animals; Benzodiazepines; Cell Membrane; Cytoplasm; Flurazepam; Glutamic Acid; Hippocampus; Kainic Acid; Male; Membrane Potentials; Membrane Proteins; Neuronal Plasticity; Patch-Clamp Techniques; Protein Transport; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Spermine; Substance Withdrawal Syndrome; Synapses; Up-Regulation | 2007 |
17beta-estradiol affects GABAergic transmission in developing hippocampus.
Topics: Age Factors; Aging; Animals; Drug Administration Schedule; Estradiol; Excitatory Amino Acid Antagonists; Female; Flurazepam; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Inhibitory Postsynaptic Potentials; Male; Neural Inhibition; Organ Culture Techniques; Patch-Clamp Techniques; Rats; Rats, Wistar; Synapses; Up-Regulation | 2008 |
Calcium/calmodulin-dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal.
Topics: Animals; Behavior, Animal; Benzodiazepines; Biophysical Phenomena; Biophysics; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Agents; Flurazepam; Gene Expression Regulation, Enzymologic; Glutamic Acid; Hippocampus; Hypnotics and Sedatives; In Vitro Techniques; Male; Neuronal Plasticity; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Subcellular Fractions; Substance Withdrawal Syndrome; Time Factors | 2010 |